MYGN 8-K 2026-11-04

MYRIAD GENETICS INC (MYGN) 8-K dated 2026-11-04 — accession 0001628280-26-070135.

MYRIAD GENETICS INC (MYGN) is a diagnostics & research company listed on NASDAQ.

MYRIAD GENETICS INC filed a 8-K on 2026-11-04. Accession 0001628280-26-070135.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.

Not investment advice. The MYGN SEC hub lists recent forms. The stock page is the research view.